Remission in Adults With Mild-to-moderate Asthma in Thailand
Status: Recruiting
Location: See all (2) locations...
Intervention Type: Other
Study Type: Observational
SUMMARY
The goal of this observational study is to determine the prevalence of remission among adults with mild-to-moderate asthma, as well as the factors associated with remission in Thailand. The main question the study aims to answer is: What is the prevalence of remission among adults with severe asthma in Thailand? Participants will complete a questionnaire on asthma symptoms and undergo pulmonary function testing and a blood test once.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:
• mild-to-moderate asthma
• age 18 years or older
Locations
Other Locations
Thailand
Faculty of Medicine, Thammasat University
RECRUITING
Pathum Thani
Narongkorn Saiphoklang
RECRUITING
Pathum Thani
Contact Information
Primary
Narongkorn Saiphoklang, MD
M_narongkorn@hotmail.com
+6629269794
Backup
Sirashat Hanvivattanakul, MD
boss32_@hotmail.com
+6629269701
Time Frame
Start Date: 2026-02-01
Estimated Completion Date: 2026-12-31
Participants
Target number of participants: 289
Treatments
Mild-to-moderate asthma
Patients aged 18 years or older with mild-to-moderate asthma. Mild asthma refers to asthma patients who experience symptoms \<3 times per week, have preserved lung function (FEV₁ or PEF \>80% of predicted), and whose symptoms can be adequately controlled with low-dose inhaled corticosteroids (low-dose ICS) alone, without the need for long-acting bronchodilators or other controller medications.~Moderate asthma refers to asthma patients who have symptoms \>4-5 days per week or experience nocturnal asthma symptoms \>1 per week, and who require treatment with medium-dose inhaled corticosteroids (medium-dose ICS) or low-dose ICS in combination with a long-acting β₂-agonist (low-dose ICS/LABA) to achieve symptom control and prevent exacerbations.
Related Therapeutic Areas
Sponsors
Leads: Thammasat University